Business Wire

Future Planet Capital Launches New €20m Blue Ocean Mandate

Share

Future Planet Capital, the international venture capital and impact investor, is pleased to announce the close of a new €20m Blue Ocean mandate aimed at tackling key issues affecting the world’s oceans.

The mandate, which Barclays Private Bank helped implement, will be partnered with the Prince Albert II of Monaco Foundation and the Monaco Government in the context of the Monaco Blue Initiative (MBI) and in the framework of the Monaco Ocean Week, at the end of March.

Managed by Future Planet Capital’s experienced investment team, including Ed Phillips, Partner and Head of Origination, and Lyle Pentith, Portfolio Manager, the Blue Ocean mandate will aim to invest in a portfolio of ten to fifteen high-growth and high-impact companies that are profitably tackling key issues within the Blue Economy.

This targeted investment strategy will focus on three areas within the Blue Economy: preventing pollution, preservation of marine environments and ecosystems and sustainable marine productivity. The vehicle will make investments predominantly at the Series A and B stage in companies creating scalable solutions to challenges such as overfishing, biodiversity loss and pollution, in addition to opportunities within clean energy, green protein, shipping and carbon capture. These companies will be carefully selected from the world’s leading innovation ecosystems and partner venture funds with whom Future Planet Capital has a connection.

Douglas Hansen-Luke, Executive Chairman at Future Planet Capital, said:“I am excited to announce the launch of the Future Planet Blue Ocean mandate and we are delighted to partner with the Prince Albert II of Monaco Foundation, which has a deep commitment to protection of the world’s oceans. This is a critical task if we are to mitigate the increasing challenge the planet faces today including the climate crisis and biodiversity loss. Future Planet Capital was an early mover in the impact investing space and with our track record of challenging global issues we look forward to seeing the impact of the Future Planet Blue Ocean.”

About Future Planet Capital

Future Planet is the impact-led venture capital firm built to back growth companies from the world's top universities and research ecosystems. Headquartered in London, but investing globally, the firm manages over $300M for institutional investors having backed over 180 companies across geographies and stages. Future Planet Capital’s goal is to profitably solve the world's greatest challenges in climate change, education, health, sustainable growth & security.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Maitland/AMO
Jonathan Cook, jcook@maitland.co.uk
Kate Pledger, kpledger@maitland.co.uk
T: 020 7379 5151

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

QCT Delivers on the 5G Promise with Innovative Edge Infrastructures and 5G Solutions16.5.2022 13:00:00 CEST | Press release

Quanta Cloud Technology (QCT), a leading data center hardware solution provider, today announced details around its participation at the Big 5G Event 2022, being held onsite from May 16 – May 18, at the Austin Convention Center in Austin, Texas. QCT will showcase 5G infrastructure and solution demos at Booth #300 for both public and private networks and share their latest insights at the event. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220516005006/en/ (Graphic: Business Wire) To support the ever-growing compute and networking needs at the telco edge, QCT showcases its latest QuantaEdge products and solutions powered by Intel Xeon-SP and Xeon-D processors, spanning carrier grade 5G systems, edge servers and radio units that are cloud native to deliver maximum deployment flexibility. QCT demo highlights include: QuantaEdge EGD33B-WT - a next-gen outdoor pole-mount edge server designed for vRAN/MEC use cases, featuring a

Solynta and Incotec Announce Partnership to Optimize Performance of Hybrid True Potato Seeds16.5.2022 12:00:00 CEST | Press release

Hybrid potato innovator Solynta and seed enhancement company Incotec have entered in a collaboration agreement. By combining forces, the group will bring world-class seed technology and elite genetics to potato farmers worldwide. Solynta is a Netherlands-based company using hybrid potato breeding to grow a more sustainable future. Solynta has developed a unique portfolio of hybrid potato varieties for farmers that are dependable, productive and resilient to climate change. Incotec, a global seed enhancement company, has developed technologies including a new pelletization method and seed priming formula specifically tailored for true potato seeds. This seed technology will allow Solynta’s true potato seeds to succeed in diverse growing environments. Johan Trouw, Solynta Supply Chain Director and co-founder, noted, “At Solynta, we believe that partnering with industry leaders like Incotec supports our mission of creating solutions for food and nutritional insecurity. Their expertise in

LIVALL Introduces the World's First Detachable Open Ear Headphones16.5.2022 10:43:00 CEST | Press release

Award-winning smart helmet company, LIVALL, is pleased to announce the upcoming launch of the World’s First Detachable Open Ear TWS Headphones. Titled “LTS21”, the headphones can be used by anybody who wants comfortable headphones. To learn more about LTS21, please visit: https://www.youtube.com/watch?v=P505tZljrb0 LIVALL prides itself in being a company that listens to customers’ needs and expectations, and the very ethos has been the foundation of the development of LTS21. Per the statements of LIVALL founder, the innovative LTS21 has been uniquely designed to ensure unparalleled comfort, performance, and convenience for users. “We are developing a cutting-edge technology accessory to match perfectly with helmets. Our team is working diligently to stay ahead in our latest innovations and offer quality products and surprises. Our latest Indiegogo campaign will allow us to provide early pricing to all of our backers. We are excited to bring our latest product and the World's First Deta

Early-Stage Investments for Turkish Metaverse Platform MetaAge Nears $1-Million Mark16.5.2022 10:00:00 CEST | Press release

MetaAge, a metaverse platform based on the Solana Blockchain, has drawn almost $1 million in early-stage investments, project managers said this week. Currently, under development in Turkey, the platform has just entered its alpha phase, during which it plans to work closely with 50 global NFT projects. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220511005497/en/ MetaAge is an augmented-reality platform where users can do practically everything they do in real life – from socializing and playing games to buying property and generating revenue. (Graphic: Business Wire) “We plan to expand globally within a relatively short period of time,” Mustafa Ekinci, MetaAge creator and co-founder, says. “The platform has already generated significant international interest,” he adds, noting that its rapidly growing Discord community now includes more than 10,000 people from all over the world, while it also got 4000 people whitelisted

Celmatix Announces Achievement of Key Preclinical Milestones in Premature Menopause Prevention Drug Program16.5.2022 09:30:00 CEST | Press release

Celmatix Inc. a biotechnology company focused on ovarian biology, today announced the identification of a novel AMHR2 agonist compound that has demonstrated robust biological activity in multiple therapeutically relevant preclinical assays and a pharmacokinetic profile consistent with the desired product profile for an injectable drug. The program, which was a product of Celmatix’s decade-long focus on identifying novel biomarkers and drug targets for women’s health, has a planned first clinical indication in the prevention of premature menopause in women undergoing chemotherapy. Loss of ovarian function and menopause are accelerated by approximately 1.5 years for each month a woman receives chemotherapy treatment. “Demographically speaking, menopause is a relatively new phenomenon and is the result of medical breakthroughs that allow women to now routinely outlive their ovarian function” remarked Dr. Piraye Yurttas Beim, Celmatix founder and CEO. “A century ago, the average life expec